These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35866930)

  • 1. Primary repair of nonsteroidal anti-inflammatory drug-associated full thickness gastrointestinal ulcers in 11 dogs.
    Dobberstein REA; Oblak ML; Brisson BA; Singh A; Moens NMM; Ayoub S
    Vet Surg; 2022 Oct; 51(7):1096-1105. PubMed ID: 35866930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric or duodenal perforation and secondary septic peritonitis following therapeutic nonsteroidal anti-inflammatory drug administration.
    Pfeifer JM; Levy NA; Carter DL; Beal MW
    J Vet Emerg Crit Care (San Antonio); 2022 Nov; 32(6):764-768. PubMed ID: 35708902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs.
    Cheatum DE; Arvanitakis C; Gumpel M; Stead H; Geis GS
    Clin Ther; 1999 Jun; 21(6):992-1003. PubMed ID: 10440623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.
    La Corte R; Caselli M; Castellino G; Bajocchi G; Trotta F
    Drug Saf; 1999 Jun; 20(6):527-43. PubMed ID: 10392669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroduodenal ulceration in dogs. Retrospective study of 43 cases and literature review.
    Stanton ME; Bright RM
    J Vet Intern Med; 1989; 3(4):238-44. PubMed ID: 2685273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression.
    Lad R; Armstrong D
    Can J Gastroenterol; 1999 Mar; 13(2):135-42. PubMed ID: 10203432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroduodenal complications of chronic NSAID therapy.
    Graham DY; Smith JL
    Am J Gastroenterol; 1988 Oct; 83(10):1081-4. PubMed ID: 3048080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroduodenal Ulcers in Liver Transplant Recipients under Immunosuppressive Therapy.
    Kakizoe K; Torisu T; Ihara Y; Harada N; Yoshizumi T; Fujioka S; Kondo M; Kitazono T
    Dig Dis; 2023; 41(4):565-571. PubMed ID: 37019093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy.
    Graham DY
    Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):675-81. PubMed ID: 2642452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcers.
    Konturek SJ; Bielański W; Płonka M; Pawlik T; Pepera J; Konturek PC; Czarnecki J; Penar A; Jedrychowski W
    Scand J Gastroenterol; 2003 Sep; 38(9):923-30. PubMed ID: 14531527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-steroidal anti-inflammatory drug-induced gastroduodenal injury: therapeutic recommendations.
    Curtis WD; Griffin JW
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():99-109. PubMed ID: 1679675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: the role of proton pump inhibitors.
    Brown GJ; Yeomans ND
    Drug Saf; 1999 Dec; 21(6):503-12. PubMed ID: 10612273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in managing NSAID-associated gastrointestinal tract injury.
    Goldstein JL
    Digestion; 2004; 69 Suppl 1():25-33. PubMed ID: 15001832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
    Graham DY
    Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful surgical management of spontaneous gastric perforations in three cats.
    Cariou MP; Halfacree ZJ; Lee KC; Baines SJ
    J Feline Med Surg; 2010 Jan; 12(1):36-41. PubMed ID: 20123485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
    al-Assi MT; Genta RM; Karttunen TJ; Graham DY
    Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.